Pharmaceuticals

Avalon Rare Metals Inc (AMEX: AVL) shares advanced 16.75% to $6.83 by 10:00 am. AVL had no debt in the recent quarter. Rare Element Res Ltd (AMEX: REE) climbed 16.71% to $13.69. REE had $11.14 million in total cash and no debt for the latest quarter. Private Media Group Inc (NASDAQ: PRVT) shares...

The US dollar stayed lower after Case-Shiller's index of home prices in 20-cities dropped 1.3% in October. The dollar index (DXY) fell 0.62% to 79.87. Against the dollar, the euro gained 0.3418% to $1.3209. Against the yen, the greenback lost 1.0751% to ¥81.8700. Shares of Santarus Inc (NASDAQ:...

Cepheid (CPHD) recently launched Xpert Flu, as a CE IVD Mark product, in line with the European directive on in vitro diagnostic devices. This test operates on Cepheid's GeneXpert System and concurrently identifies and differentiates Flu A, Flu B and 2009 H1N1 influenza virus in about an hour....

The US Food and Drug Administration (FDA) has meted out a severe blow to Regeneron Pharmaceuticals Inc. (REGN) and partner Sanofi-Aventis (SNY) by halting the development of REGN475/SAR164877, which was being developed for treating pain associated with osteoarthritis. Regeneron stated that no...

RC2 Corporation (NASDAQ: RCRC) was downgraded by Caris from "above average" to "average." RCRC's shares closed at $22.90 yesterday. RCRC's PEG ratio is 1.40. Eurand NV (NASDAQ: EURX) was downgraded by Roth Capital from "buy" to "neutral." EURX's stock closed at $11.73 yesterday. Eurand's trailing-...

The US Food and Drug Administration (FDA) has meted out a severe blow to Regeneron Pharmaceuticals Inc. (REGN) and partner Sanofi-Aventis (SNY) by halting the development of REGN475/SAR164877, which was being developed for treating pain associated with osteoarthritis. Regeneron stated that no...

Santarus Inc (NASDAQ: SNTS) rose 7.26% to $3.40 in the pre-market session. SNTS and Pharming Group NV (NYSE: PHARM) submitted a Biologics License Application (BLA) for RHUCIN to the US Food and Drug Administration (FDA). MannKind Corporation (NASDAQ: MNKD) added 5.40% to $8.40 in pre-market trading...

Cepheid (CPHD) recently launched Xpert Flu, as a CE IVD Mark product, in line with the European directive on in vitro diagnostic devices. This test operates on Cepheid's GeneXpert System and concurrently identifies and differentiates Flu A, Flu B and 2009 H1N1 influenza virus in about an hour....

Specialty biopharmaceutical company Santarus, Inc. (NASDAQ: SNTS) and biotech company Pharming Group NV (NYSE: PHARM) today announced the submission of a Biologics License Application to the U.S. Food and Drug Administration to obtain marketing approval for RHUCIN for the treatment of acute...

Piper Jaffray has an Overweight rating and a $7 price target on shares of Somaxon Pharmaceuticals (NASDAQ: SOMX). In a note sent to clients, Piper Jaffray writes, "Yesterday, Somaxon announced that it received notice of an abbreviated NDA (aNDA) filing under paragraph IV (PIV) for a generic...

Below are the top small-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio. PDL BioPharma Inc (NASDAQ: PDLI) has a PEG ratio of 0.27. PDLI's trailing-twelve-month operating margin is 89.34%. Exelixis Inc (NASDAQ: EXEL) has a PEG ratio of 0.33. EXEL's trailing-twelve-month...

Cusick's Corner The major markets remained quiet throughout today's trading session. This slower week may be a good time to do a little Watchlist housekeeping. Update your Watchlist entries in your optionsXpress account by logging into your account and clicking on Account tab > Alert Manager. You...

Caraco Pharmaceutical Laboratories, Ltd. (AMEX: CPD) announced that the two distribution agreements with Sun Pharmaceutical Industries Limited (Sun) have been extended until January 28, 2012 but will each terminate following these extensions. The marketing agreement, which was originally set to...

Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the "Amendment") to effect a 1-for-15 share consolidation, or reverse stock split ("reverse split"), effective at 12:01 a.m. on December...

Here is our latest update on the stock trading technique called 'Buying Dividends'. This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only...